Developing new treatments for childhood cancers
NCI Research Specialist (Clinician Scientist) Award
This study is looking for new and better treatments for kids with solid tumors like neuroblastoma, and it gives young patients a chance to join clinical trials that test these exciting new options while also working to reduce side effects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11063248 on NIH RePORTER |
What this research studies
This research focuses on advancing novel therapies for pediatric patients with solid tumors, particularly neuroblastoma. Led by a Pediatric Hematologist-Oncologist, the project aims to implement early-phase clinical trials that test new treatment options while also addressing the side effects associated with these therapies. The research involves collaboration with national clinical trial networks to ensure comprehensive care and innovative approaches to treatment. Patients may have the opportunity to participate in these trials, contributing to the development of safer and more effective cancer treatments for children.
Who could benefit from this research
Good fit: Ideal candidates for participation are pediatric patients diagnosed with solid tumors, particularly those with neuroblastoma or relapsed/refractory disease.
Not a fit: Patients with non-solid tumors or those who are not pediatric cancer patients may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for children with cancer.
How similar studies have performed: Previous research in pediatric oncology has shown success in developing new therapies through early-phase clinical trials, indicating a promising approach.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Foster, Jennifer Haunani — Baylor College of Medicine
- Study coordinator: Foster, Jennifer Haunani
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.